Is it time for recommendations to reflect reality in PSC surveillance?
作者信息
Hawken James, Appanna Gautham, Portal A J
机构信息
Bristol Liver Unit, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
出版信息
Frontline Gastroenterol. 2021 Mar 23;13(1):88-89. doi: 10.1136/flgastro-2021-101812. eCollection 2022.
Abstract
摘要
相似文献
1
Is it time for recommendations to reflect reality in PSC surveillance?
Frontline Gastroenterol. 2021 Mar 23;13(1):88-89. doi: 10.1136/flgastro-2021-101812. eCollection 2022.
2
Role of Peroral Cholangioscopy in the Diagnosis of Primary Sclerosing Cholangitis.
Diagnostics (Basel). 2020 Apr 29;10(5):268. doi: 10.3390/diagnostics10050268.
3
Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices.
Expert Rev Gastroenterol Hepatol. 2021 May;15(5):487-496. doi: 10.1080/17474124.2021.1900732. Epub 2021 Apr 19.
4
Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Eur Radiol. 2022 Feb;32(2):923-937. doi: 10.1007/s00330-021-08147-7. Epub 2021 Aug 6.
5
AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.
Clin Gastroenterol Hepatol. 2019 Nov;17(12):2416-2422. doi: 10.1016/j.cgh.2019.07.011. Epub 2019 Jul 12.
6
Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
Gut. 2017 Jan;66(1):137-144. doi: 10.1136/gutjnl-2016-311739. Epub 2016 Jul 12.
7
Cancer Risk and Surveillance in Primary Sclerosing Cholangitis.
Clin Liver Dis. 2016 Feb;20(1):79-98. doi: 10.1016/j.cld.2015.08.014. Epub 2015 Oct 21.
8
Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
Clin Rev Allergy Immunol. 2020 Feb;58(1):134-149. doi: 10.1007/s12016-019-08764-7.
9
Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis.
Abdom Radiol (NY). 2017 Dec;42(12):2898-2908. doi: 10.1007/s00261-017-1328-8.
10
Primary sclerosing cholangitis in children versus adults: lessons for the clinic.
Expert Rev Gastroenterol Hepatol. 2018 Oct;12(10):1025-1032. doi: 10.1080/17474124.2018.1521719. Epub 2018 Oct 1.
引用本文的文献
1
Surveillance imaging in primary sclerosing cholangitis (PSC): evidence, patient preference and physician autonomy.
Transl Gastroenterol Hepatol. 2022 Oct 25;7:43. doi: 10.21037/tgh-21-87. eCollection 2022.
本文引用的文献
1
Guideline review: British Society of Gastroenterology/UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.
Frontline Gastroenterol. 2020 Mar 2;12(1):62-66. doi: 10.1136/flgastro-2019-101343. eCollection 2021.
2
AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.
Clin Gastroenterol Hepatol. 2019 Nov;17(12):2416-2422. doi: 10.1016/j.cgh.2019.07.011. Epub 2019 Jul 12.
3
British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.
Gut. 2019 Aug;68(8):1356-1378. doi: 10.1136/gutjnl-2018-317993. Epub 2019 Jun 1.
4
Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline.
Endoscopy. 2017 Jun;49(6):588-608. doi: 10.1055/s-0043-107029. Epub 2017 Apr 18.
5
Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.
Clin Gastroenterol Hepatol. 2015 Nov;13(12):2152-65. doi: 10.1016/j.cgh.2015.05.035. Epub 2015 Jun 5.
6
EASL Clinical Practice Guidelines: management of cholestatic liver diseases.
J Hepatol. 2009 Aug;51(2):237-67. doi: 10.1016/j.jhep.2009.04.009. Epub 2009 Jun 6.
7
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.
Scand J Gastroenterol. 2002 Oct;37(10):1205-11. doi: 10.1080/003655202760373434.
Zotero 插件